2m 2m 2m 2m 2m 2m 2m
NUVECTIS PHARMA (NVCT)
NASDAQ
$20.89-$0.001 (-0.005%)
Price as of Oct 23, 2026 4:09 AM EDT- $681.9MMarket Cap
- 247.59%1-Year Change
- BiotechnologyIndustry
NUVECTIS PHARMA (NVCT)
$20.89-$0.001 (-0.005%)
NVCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $20.89 | ||
Change | +$0.19 (+0.92%) | ||
Open | $20.55 | ||
High | $21.26 | ||
Low | $20.40 | ||
Previous Close | $20.70 | ||
Volume | 110,052 | ||
30-Day Average Volume | 174,553 | ||
1-Week Change | 10.35% | ||
1-Month Change | -9.17% | ||
1-Year Change | 247.59% | ||
3-Year Change | 127.31% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 32.6M | ||
Total Assets | $22.4M | ||
Market Cap | $681.9M | ||
Enterprise Value | $659.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$7.0M | ||
Free Cash Flow | -$4.5M | ||
EBIT | -$7.0M | ||
EBITDA | -$7.0M | ||
Net Working Capital | $9.1M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | -94 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 75 | ||
P/E | -70 | ||
PEG | 5 | ||
Price/Free Cash Flow | -151 | ||
Price/Operating Cash Flow | -151 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue